AbbVie, Shire, Pfizer offended by turning Vicodin, Adderall, Xanax into fashion statement

Eric Palmer AbbVie, Shire and Pfizer are unamused and unimpressed by a designer's use of the names of their drugs Vicodin, Adderall and Xanax as a fashion statement. The new T-shirts ...

Report: Humira Climbs into Top 5 in Q2 Drug Sales

barbara.lempert Drugs.com Releases Q2 Sales for Top 100 U.S. Prescription Drugs: Humira Climbs into Top 5 and Posts Double-Digit Growth NEW YORK, Aug. 14, 2013 /PRNewswire/ ...

Medigene and Difa Cooper Enter Into Agreement for the Commercialization of Veregen in Italy

barbara.lempert Medigene and Difa Cooper enter into agreement for the commercialization of Veregen® in Italy Martinsried/Munich, 06 August, 2013. Medigene AG (MDG, Frankfurt, Prime ...

Roche throws HIV blindness drug Valcyte into patent pool

Carly Helfand Roche has signed an agreement with the Medicines Patent Pool to surrender Valcyte's patent and make the drug available in developing countries by slashing costs by ...

Omeros eyes first approval for combo eye drug; MorphoSys plans jump into immunotherapy work;

John Carroll FierceBiotech News

Actelion enters into an agreement to acquire privately-held Ceptaris Therapeutics

barbara.lempert VALCHLOR(TM) gel under FDA Review for Early-Stage Mycosis Fungoides-Type CTCL ALLSCHWIL/BASEL, SWITZERLAND and MALVERN, PA – 31 July 2013 – Actelion US ...

Pfizer splitting operations into three units

Emily Mullin Pfizer is doing some reorganization–the company said Monday that it would split its operations into three distinct units, two focused on "innovative" drugs ...

Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for Belviq

barbara.lempert Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Taiwan SAN DIEGO, July 25, 2013 /PRNewswire/ — ...

Roche plows $105 million into training center to feed expansion of Swiss logistics plant

Eric Palmer Roche is building a $ 105 million training center at a key plant in the Swiss company's home country. FiercePharma News

‘Reverse’ DNA vaccine bursts into the spotlight with promising Type 1 diabetes data

John Carroll A stealth biotech spun out of Stanford University burst into public view today, drawing headlines around the world for its new therapeutic approach to Type 1 diabetes that ...

Pluristem Enters into Strategic Partnership and Licensing Agreement with Cha Bio&Diostech

barbara.lempert Pluristem Enters into Strategic Partnership and Licensing Agreement with Cha Bio&Diostech for the Development and Commercialization of PLX cells for the Treatment ...

Celgene jumps into blood-cancer race with J&J, adding $818M MorphoSys deal

John Carroll     FierceBiotech News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS